Manufacturer copay assistance · Rituxan (J9312) · Genentech
$5 drug + $5 admin/dose · Maximum benefit $15,000 drug + $2,000 administration per calendar year · Covers Rituxan drug cost AND infusion administration — separate caps apply
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Rituxan — the program's cap applies against the patient share CareCost calculates.
Yes — Genentech Co-pay Assistance Program from Genentech. Patient pays $5 for drug and $5 for administration per infusion. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $5 for drug and $5 for administration per infusion Maximum benefit: $15,000 drug + $2,000 administration per calendar year. Covers Rituxan drug cost AND infusion administration — separate caps apply
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.
Yes — enrollment can be backdated 180 days from enrollment date. Timely filing: 365 days from date of service.